Zai LabZLAB -0.21%64 EV-to-OCF is -17.12 as of Jul. 05, 2026. GuruFocus rates ZLAB with a GF Score™ of 64/100 and a GF Value™ of $30.26 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 1,413 Biotechnology companies, Zai Lab ranks better than 78.27% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Zai Lab's Enterprise Value is $1,729.3 Mil.
Zai Lab's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-101.0 Mil. Therefore, Zai Lab's EV-to-OCF for today is -17.12.
The historical rank and industry rank for Zai Lab's EV-to-OCF or its related term are showing as below:
ZLAB'
s EV-to-OCF Range Over the Past 10 Years
Min: -148.31 Med: -10.52 Max: -2.64
Current: -17.12
During the past 11 years, the highest EV-to-OCF of Zai Lab was -2.64. The lowest was -148.31. And the median was -10.52.
ZLAB's EV-to-OCF is ranked better than 78.27% of 1413
companies
in the Biotechnology industry
Industry Median: -3.58
vs ZLAB: -17.12
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-05), Zai Lab's stock price is $19.135.
Zai Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.700. Therefore, Zai Lab's PE Ratio (TTM) for today is At Loss.
Zai Lab (NAS:ZLAB) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zai Lab's share price for today is $19.135.
Zai Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.700.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Zai Lab EV-to-OCF Related Terms
Zai Lab EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Zai Lab's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zai Lab's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zai Lab EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zai Lab's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Zai Lab's EV-to-OCF falls into.
Zai Lab's current Enterprise Value is $1,729.3 Mil.
Zai Lab's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-101.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zai Lab (ZLAB) has a EV-to-OCF of -17.12 as of Jul. 05, 2026. According to the industry distribution chart, Zai Lab ranks #307 out of 1413 companies in the Biotechnology industry, placing it in the top 21.7%.
Is Zai Lab's EV-to-OCF too high?
Zai Lab's current EV-to-OCF is -17.12. Based on the distribution chart, Zai Lab ranks #307 out of 1413 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Zai Lab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zai Lab's EV-to-OCF compare to STOK and ADMA?
According to the Biotechnology industry distribution chart, Zai Lab ranks #307 out of 1413 companies for EV-to-OCF. This places Zai Lab in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Zai Lab's current EV-to-OCF is -17.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zai Lab stock overvalued right now?
Based on GuruFocus' analysis, Zai Lab (ZLAB) is currently considered Possible Value Trap. The stock's GF Value™ is $30.26, compared to a current price of $19.14 — trading 36.8% below its estimated fair value. The current EV-to-OCF is -17.12. Zai Lab's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Zai Lab (ZLAB), the current EV-to-OCF is -17.12 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zai Lab (ZLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued.
The current stock price of $19.14 is trading 36.8% below its estimated GF Value™ of $30.26.
GuruFocus considers Zai Lab to be Possible Value Trap.
Key valuation signals for ZLAB:
EV-to-OCF: -17.12
GF Value™: $30.26 vs. price of $19.14 (36.8% below fair value)
No single metric tells the full story. See the ZLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
64GF Score
Get the complete analysis for ZLAB
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZLAB has been successfully added to your 
